fluorodopa f 18 has been researched along with Thoracic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
Carrasquillo, JA; Chen, CC; Chowdhury, I; Gharib, AM; Gundabolu, B; Nieman, LK; Sinaii, N; Whatley, M; Zemskova, MS | 1 |
2 other study(ies) available for fluorodopa f 18 and Thoracic Neoplasms
Article | Year |
---|---|
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Somatostatin; Thoracic Neoplasms | 2010 |